Although many studies have reported that the expression of CD44, CD44v, CD133, EpCAM and ALDH1A1 is associated with tumor progression and can be used to predict patient’s outcome, their prognostic significance in the recurrence of CCA in patients has not been elucidated. The gene discussed is CD44; the disease is cholangiocarcinoma.